Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study

[Image: see text] Background. COVID-19, caused by the SARS-CoV-2 virus, is a pandemic disease with high morbidity and mortality. Currently, available therapeutic options for COVID-19 are limited. Prior experience in epidemics with convalescent plasma (CP) containing antibodies to viruses has demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: Khanna, Nina, Weisser, Maja, Hedstueck, Anemone, Sutter, Sarah Tschudin, Roesch, Sandra, Battegay, Manuel, Infanti, Laura, Holbro, Andreas, Busch, Michael Paul, Simmons, Graham, Felgner, Philip, Stone, Mars, von Goetz, Melissa, de Assis, Rafael, Khan, Saahir, Tsai, Jason, Robinson, Peter, Seftel, David, Bagri, Anil, Corash, Laurence, Buser, Andreas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
401.Basic Science and Clinical Practice in Blood Transfusion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330279/
http://dx.doi.org/10.1182/blood-2020-136180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330279/
http://dx.doi.org/10.1182/blood-2020-136180

Ejemplares similares